Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tripartite motif-containing protein 64B (TRIM64B) is a putative member of the TRIM protein family, characterized by a conserved RBCC motif containing a RING domain, one or two B-box domains, and a coiled-coil domain[1][2][4]. TRIM64B is predicted to have ubiquitin protein ligase (E3 ligase) activity, and to be involved in the innate immune response and regulation of gene expression, functioning primarily in the cytoplasm[1][5][6]. However, there are currently no reports associating TRIM64B directly with specific human diseases, therapeutic interventions, or interacting drugs. TRIM64B remains poorly characterized, with much of its molecular and biological function inferred from its membership in the broader TRIM family—which is involved in processes such as autophagy, immunity, and protein regulation[2][4]. There is no strong evidence currently supporting TRIM64B as a direct therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tripartite motif-containing protein 64B (TRIM64B).